These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25621961)

  • 1. What is the role of sofosbuvir in treating hepatitis C infection?
    Carey L
    JAAPA; 2015 Feb; 28(2):16-9. PubMed ID: 25621961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sofosbuvir in the treatment of chronic hepatitis C: new dog, new tricks.
    Abraham GM; Spooner LM
    Clin Infect Dis; 2014 Aug; 59(3):411-5. PubMed ID: 24748524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure.
    Kalal C; Shukla A; Mohanka R; Vora M; Patel P; Shah S
    Hepatology; 2018 May; 67(5):2049-2050. PubMed ID: 29152769
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.
    Tang L; Ward H; Kattakuzhy S; Wilson E; Kottilil S
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):21-36. PubMed ID: 26558305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.
    Bourlière M; Adhoute X; Ansaldi C; Oules V; Benali S; Portal I; Castellani P; Halfon P
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1483-94. PubMed ID: 26595560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
    Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection.
    Childs-Kean LM; Hand EO
    Clin Ther; 2015 Feb; 37(2):243-67. PubMed ID: 25601269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?
    Brochot E; Bodeau S; Duverlie G
    Ther Drug Monit; 2015 Aug; 37(4):550-1. PubMed ID: 25525764
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: safety and efficacy of sofosbuvir plus daclatasvir with ribavirin for 12 weeks in Chinese treatment-experienced cirrhotic genotype 1b patients with HCV.
    Zeng QL; Li CX; Zhang DW; Li W; Xu GH; Yu ZJ
    Aliment Pharmacol Ther; 2016 Apr; 43(7):842-3. PubMed ID: 26932414
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection.
    Sundaram V; Kowdley KV
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):13-20. PubMed ID: 26560449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3].
    Jung YK
    Korean J Gastroenterol; 2016 Mar; 67(3):132-6. PubMed ID: 26996182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus genotype 4: Genotype 1's little brother.
    Llaneras J; Riveiro-Barciela M; Buti M; Esteban R
    J Viral Hepat; 2017 Jan; 24(1):4-12. PubMed ID: 27905173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing the face of hepatitis C management - the design and development of sofosbuvir.
    Noell BC; Besur SV; deLemos AS
    Drug Des Devel Ther; 2015; 9():2367-74. PubMed ID: 25987834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.
    Maciocia N; O'Brien A; Ardeshna K
    N Engl J Med; 2016 Oct; 375(17):1699-1701. PubMed ID: 27783921
    [No Abstract]   [Full Text] [Related]  

  • 15. Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant.
    Punzalan CS; Barry C; Zacharias I; Rodrigues J; Mehta S; Bozorgzadeh A; Barnard GF
    Clin Transplant; 2015 Dec; 29(12):1105-11. PubMed ID: 26358816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of sofosbuvir for the treatment of hepatitis C virus infection.
    Lawitz E; Jacobson IM; Nelson DR; Zeuzem S; Sulkowski MS; Esteban R; Brainard D; McNally J; Symonds WT; McHutchison JG; Dieterich D; Gane E
    Ann N Y Acad Sci; 2015 Nov; 1358():56-67. PubMed ID: 26235748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir.
    Schreiber J; McNally J; Chodavarapu K; Svarovskaia E; Moreno C
    Hepatology; 2016 Sep; 64(3):983-5. PubMed ID: 27177605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy.
    Singal AG; Waljee AK; Shiffman M; Bacon BR; Schoenfeld PS
    Aliment Pharmacol Ther; 2010 Oct; 32(8):969-83. PubMed ID: 20937042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison.
    Swallow E; Song J; Yuan Y; Kalsekar A; Kelley C; Mu F; Kim S; Noviello S; Signorovitch J
    J Comp Eff Res; 2016 Mar; 5(2):129-39. PubMed ID: 26390233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.